CLNN · Clene Inc
United States · RS rating 22 · As of 2026-11-03
| Price | 3.77 USD |
|---|---|
| 1-day change | +4.4% |
| RS rating (overall / 1M / 3M / 12M) | 22 / 48 / 21 / 13 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 6 / 11 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -56.5% |
| Sales growth Q/Q | +413.3% |
| Distance from 52-week high | +68.5% |
| Market cap (USD) | $72.4M |